Skip to Content

Elekta AB ADR EKTAY

Morningstar Rating
$8.03 +0.02 (0.19%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

EKTAY is trading at a 274% premium.
Price
$8.01
Fair Value
$1.84
Uncertainty
High
1-Star Price
$56.14
5-Star Price
$7.69
Economic Moat
Dkhv
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if EKTAY is a good fit for your portfolio.

Trading Information

Previous Close Price
$8.01
Day Range
$7.988.03
52-Week Range
$6.528.62
Bid/Ask
$7.84 / $8.17
Market Cap
$3.07 Bil
Volume/Avg
3,435 / 8,733

Key Statistics

Price/Earnings (Normalized)
20.04
Price/Sales
1.79
Dividend Yield (Trailing)
2.81%
Dividend Yield (Forward)
2.81%
Total Yield
2.81%

Company Profile

Sweden-based Elekta develops, manufactures, and distributes treatment planning systems for neurosurgery and radiotherapy, including stereotactic radiosurgery and brachytherapy. The company has an installed base of more than 7,000 linear accelerators, Gamma Knife and Unity platforms, as well as brachytherapy installations. The company's sales are evenly distributed across geographies, with North and South America accounting for 31%; Europe, the Middle East, and Africa accounting for 35%; and the Asia-Pacific contributing the remainder.
Sector
Healthcare
Industry
Medical Instruments & Supplies
Stock Style Box
Mid Core
Total Number of Employees
4,584

Competitors

Valuation

Metric
EKTAY
ISRG
BDX
Price/Earnings (Normalized)
20.0467.0418.85
Price/Book Value
3.1110.182.60
Price/Sales
1.7919.643.40
Price/Cash Flow
11.8451.6718.80
Price/Earnings
EKTAY
ISRG
BDX

Financial Strength

Metric
EKTAY
ISRG
BDX
Quick Ratio
0.824.410.46
Current Ratio
1.095.551.08
Interest Coverage
7.214.17
Quick Ratio
EKTAY
ISRG
BDX

Profitability

Metric
EKTAY
ISRG
BDX
Return on Assets (Normalized)
4.76%14.71%3.59%
Return on Equity (Normalized)
14.30%17.05%7.46%
Return on Invested Capital (Normalized)
10.01%15.21%5.23%
Return on Assets
EKTAY
ISRG
BDX
See how this stock stacks up to its competitors with Morningstar Investor

Medical Instruments & Supplies Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ISRG
Intuitive Surgical IncPqjwwhgmdcKdpj$142.2 Bil
BDX
Becton Dickinson & CoSqthbsqzbRdsytcv$67.8 Bil
ALC
Alcon IncJzjjbtclHqdfvjg$44.6 Bil
RMD
ResMed IncGhqqqdmsgfMbcsr$32.1 Bil
CLPBY
Coloplast A/S ADRWswdmflxgzBnsy$28.0 Bil
WST
West Pharmaceutical Services IncMxbkqvbgnfNsb$24.5 Bil
COO
The Cooper Companies IncRmfxcclkqCfyfgp$18.8 Bil
HOLX
Hologic IncMdrdbnnThcfvj$17.5 Bil
BAX
Baxter International IncHxxgsbtdhSmrgg$17.3 Bil
TFX
Teleflex IncCmpxzYfwnn$10.3 Bil

Sponsor Center